board of directors

Mr. Peter Malone Executive Chairman

Mr. Malone has over 30 years of experience in global capital markets and has been responsible for raising over A$100 million for technology development companies. He has a proven track record in developing and managing technology development programs from idea to reality. A former CEO of listed companies, he holds a master’s degree from UWA and has taught and consulted in Australia, the United States, Europe and Asia in business and management. Mr. Malone is responsible for the strategic direction of the Company and is its Managing Director and Chief Executive Officer of the Company.

Mr. Phil Giglia General Secretary

Mr. Giglia is a Chartered Accountant with over 25 years of experience in management positions, with strong expertise in the small and medium business sector. Mr. Giglia worked for the world’s leading accounting firm Price Waterhouse Coopers from 1985 to 1991. He is a director of the Perth accounting firm, Giglia & Associates, is also a director of Global Marine Enclosures PL. He holds a Bachelor of Commerce (Honours) from Western Australia. Institute of Technology, member of the Institute of Chartered Accountants in Australia/NZ.

Mr. Lee Christensen Independent Non-Executive Director

Mr. Christensen is the Principal of CX Law, a progressive law firm in Perth, Western Australia. He has over 30 years of experience as an attorney and barrister in corporate and commercial law, in particular restructuring and solvency, and ASX and ASIC regulatory matters. He is also Chairman of ASX listed company Titanium Sands Limited. Mr. Christensen holds a Bachelor of Laws, a Bachelor of Jurisprudence and a Bachelor of Commerce from the University of Western Australia and was previously a partner at Gadens in Perth.

Moving from R&D to commercialization

FY21 and Recent Company Highlights

TGA Registration for SuprCuvr Biological Formula, as a 99.99999% Hospital Grade COVID-19 Disinfectant

(LOG 7), the highest score in the world.

Commercialization in progress with Australian and New Zealand SuprCuvr in a distribution agreement with Pacific

Health care.

SuprCuvr’s first $1.2 million order has already been received from Pacific Healthcare and has been executed.

Ongoing manufacturing in its SE Formula product lines, including SuprCuvr, Soléo Organics and

PapayaActivs.

Obtained a $20 million equity financing facility over the next three years with LDA Capital.

$1.4 million R&D rebate funding.

Equity raising of $4.8 million.

Branding and marketing initiatives implemented to support distribution, including new Shopify website.

TGA records enabling the opportunity

Additional independent product line certification

Our SKNProtect division was born out of 10 years of research and development that resulted in a major breakthrough in sun protection technology. Based on all natural and organic ingredients, our award-winning sunscreen cream, Soléo Organics, is formulated to protect you from the sun’s UV-A and UV-B rays while providing natural moisturizing care for your skin.

– TGA, FDA and EU registered

This division was built around our proprietary papaya filtrate containing by far the highest percentage of SE papaya formula on the market. We have developed a range of products to cleanse, hydrate, revitalize and more generally take care of your skin. Our therapeutic range has been developed using this powerful base of papaya extract supplemented with proven ingredients used in traditional herbal medicine to treat a range of skin conditions.

– Registered with the TGA

This division is home to both Invisi Shield hand sanitizers and SuprCuvr, the hospital-grade sanitizer, TGA registered to be 1,000 times more effective against COVID-19 than a 99.99% effective sanitizer. Completely free of chemicals and alcohol, our SKN Shield antimicrobial ranges continue to grow.

Invisi Shield & SuprCuvr are non-stinging, non-drying, non-greasy, non-sticky, fragrance-free, and plant-based.

– Registered with the TGA

This division is dedicated to bringing you all natural and organic cosmetics with ingredients such as Argireline and Cannabis carefully selected after independent scientific research. The entire Elizabeth Jane product range is therefore ideal for sensitive skin and offers an effective alternative to cosmetic treatments based on synthetic chemicals for your skin.

Ready to disrupt the global chemical-based disinfectant market

SuprCuvr has been listed on the Australian Register of

Therapeutic goods.

SuprCuvr is approved to claim 99.99999% efficacy (LOG 7 reduction) against COVID-19.

SuprCuvr is approved to claim 1000x as effective as a 99.99% effective disinfectant against COVID-19.

“We are delighted to have obtained registration of Invisi Shield SuprCuvr with the Therapeutic Goods Administration as a hospital-grade disinfectant. We see the potential to provide a 100% effective plant-based disinfectant in large facilities. commercialas a major opportunity for Invisi-Shield SuprCuvr and the Company.”

This is an excerpt from the original content. To continue reading it, access the original document here.